Martin Cross
Direktor/Vorstandsmitglied bei Nhmrc National Institute of Dementia Research
Vermögen: 14 661 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Matthew Dudek | M | - | 4 Jahre | |
Nigel Lange | M | - | 4 Jahre | |
Scott Greasley | M | - | 2 Jahre | |
Sandy Beard | M | 58 | 2 Jahre | |
Karen Matthews | F | - | 1 Jahre | |
David Turner | M | - | 3 Jahre | |
Harry Werner Kirsch | M | 59 | 21 Jahre | |
Phillip Christopher | M | - | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Maria Julianna Halasz | F | - | 15 Jahre | |
Ulrich Lehner | M | 78 | 13 Jahre | |
Bruce Gordon | M | - | 7 Jahre | |
Wendelin Wiedeking | M | 72 | 11 Jahre | |
Roger Aston | M | 68 | 8 Jahre | |
Chris Roberts | M | 70 | 5 Jahre | |
Nick Falzon | M | - | 1 Jahre | |
Fintan Walton | M | - | 5 Jahre | |
Tom Milicevic | M | - | 4 Jahre | |
Srikant T. Madhav Datar | M | 70 | 18 Jahre | |
Daniel Kenny | M | - | 6 Jahre | |
Otto Buttula | M | - | 2 Jahre | |
David King | M | - | 12 Jahre | |
Karl Pechmann | M | - | 3 Jahre | |
Jürgen Brokatzky-Geiger | M | 72 | 14 Jahre | |
Dario Eklund | M | 56 | 8 Jahre | |
Atul Khosia | M | - | - | |
Karim Hanna | M | - | 5 Jahre | |
Antony Mattessich | M | 57 | 2 Jahre | |
Enrique Carrazana | M | 62 | 9 Jahre | |
Peter Maag | M | 57 | 1 Jahre | |
Royston Glasspool | M | 61 | 10 Jahre | |
Bruce F. Fleming | M | 66 | 1 Jahre | |
John Hohneker | M | 64 | 14 Jahre | |
Jose Carmona | M | 51 | 12 Jahre | |
Ashish Soman | M | - | 4 Jahre | |
Kevin Smith | M | - | 1 Jahre | |
Raymond Ting | M | - | 1 Jahre | |
Michael Warrener | M | - | 5 Jahre | |
Lee Tamplin | M | - | 5 Jahre | |
Ricky Sharma | M | - | - | |
Rosh Dias | M | - |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | 10 Jahre |
Brian Hubbard | M | - | 6 Jahre | |
Mauro Ghilardi | M | 57 | 9 Jahre | |
Larry P. Allgaier | M | - | 6 Jahre | |
Hans-Martin Blickensdoerfer | M | 59 | 2 Jahre | |
Michael Bassett | M | - | 3 Jahre | |
Paolo Baroldi | M | 73 | 4 Jahre | |
Pierre F. Dodion | M | 69 | 4 Jahre | |
Paul Herrling | M | 78 | - | |
Silke Zentner | F | - | - | |
Norman Walker | M | - | 5 Jahre | |
Paul Choffat | M | - | 5 Jahre | |
Gilbert Wenzel | M | 68 | 3 Jahre | |
Mihael Polymeropoulos | M | 64 | 5 Jahre | |
Steven Kelmar | M | 70 | 4 Jahre | |
James New | M | 70 | 2 Jahre | |
Reinhard Ambros | M | 67 | 4 Jahre | |
Brian Leedman | M | - | 1 Jahre | |
Emma Pollard | F | 51 |
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | 2 Jahre |
Guy Rousseau | M | - | 6 Jahre | |
Jinzi Wu | M | 61 | 10 Jahre | |
Dennis K. Eck | M | 80 | 4 Jahre | |
Peter Nicklin | M | 61 | 2 Jahre | |
Ludwig Hantson | M | 61 | 9 Jahre | |
Ravi Anand | M | 67 | 4 Jahre | |
George Gunn | M | 74 | 12 Jahre | |
Fredrik Ollila | M | - | - | |
John Montgomery | M | - |
Alphapharm Pty Ltd.
Alphapharm Pty Ltd. Pharmaceuticals: GenericHealth Technology Alphapharm has been developing and making generic medicines in Australia for more than 25 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, It has become the largest supplier of medicines to the government subsidised Pharmaceutical Benefits Scheme and Australia's leader in generic medicines. Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US. Globally, Alphapharm is part of Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third-largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. | 12 Jahre |
Thomas McCourt | M | 66 | 7 Jahre | |
Ralph Peters | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweiz | 39 | 56,52% |
Australien | 30 | 43,48% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Martin Cross
- Persönliches Netzwerk